New synthesis of 1,4 benzodiazepine-2,5-diones by means of HCl gas catalyst

Article abstract of DOI:10.1080/00397919308013783

A new synthesis of 1,4-benzodiazepinediones 4, particularly 1,4-dihydro1H-1,4-benzodiazepine-2,5-dione, 4c key intermediate of metabolites cyclopenin 9, cyclopenol 10, cyclopeptine 11 and dehydrocyclopeptide 12, was achieved by action of dry HCl gas in DM

Full text of DOI:10.1080/00397919308013783

This article was downloaded by: [RMIT University]
On: 17 February 2013, At: 07:19
Publisher: Taylor & Francis
Informa Ltd Registered in England and Wales Registered Number: 1072954
Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH,
UK
Synthetic Communications: An
International Journal for Rapid
Communication of Synthetic
Organic Chemistry
Publication details, including instructions for
authors and subscription information:
http://www.tandfonline.com/loi/lsyc20
New Synthesis of 1,4
Benzodiazepine-2,5-diones by
Means of HCL Gas Catalyst
M. Akssira a , M. Boumzebra a , H. Kasmi a , A.
Dahdouh a , M. L. Roumestant b & Ph. Viallefont b
a Laboratoire de Chimie Organique, Université
Abdelmalek Essaadi, Faculté des Sciences,
M'hannech, BP 2121-Tétouan-MAROC
b Laboratoire d'Aminoacides et de Peptides URA 468,
Université Montpellier II, place Eugène Bataillon,
34095, Montpellier-Cedex, 5, FRANCE
Version of record first published: 23 Sep 2006.
To cite this article: M. Akssira , M. Boumzebra , H. Kasmi , A. Dahdouh , M. L.
Roumestant & Ph. Viallefont (1993): New Synthesis of 1,4 Benzodiazepine-2,5-diones
by Means of HCL Gas Catalyst, Synthetic Communications: An International Journal for
Rapid Communication of Synthetic Organic Chemistry, 23:16, 2265-2272
To link to this article: http://dx.doi.org/10.1080/00397919308013783
PLEASE SCROLL DOWN FOR ARTICLE
Full terms and conditions of use: http://www.tandfonline.com/page/terms-
and-conditions
This article may be used for research, teaching, and private study purposes.
Any substantial or systematic reproduction, redistribution, reselling, loan,

sub-licensing, systematic supply, or distribution in any form to anyone is
expressly forbidden.
The publisher does not give any warranty express or implied or make any
representation that the contents will be complete or accurate or up to
date. The accuracy of any instructions, formulae, and drug doses should be
independently verified with primary sources. The publisher shall not be liable
for any loss, actions, claims, proceedings, demand, or costs or damages
whatsoever or howsoever caused arising directly or indirectly in connection
with or arising out of the use of this material.